Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Int J Clin Pract ; 57(6): 547-8, 2003.
Article in English | MEDLINE | ID: mdl-12918898

ABSTRACT

Phaeochromocytomas are rare endocrine tumours that secrete excessive amounts of catecholamines and can lead to myocarditis and cardiomyopathy. We report a 63-year-old man with long-standing hypertension and diabetes who presented with dilated cardiomyopathy, which was initially thought to be secondary to ischaemic heart disease. Subsequent coronary angiography was normal. Carvedilol therapy unmasked the characteristic features of phaeochromocytoma. Surgical resection of a right adrenal tumour cured his symptoms, hypertension and diabetes, as well as causing a substantial improvement in cardiac function. Phaeochromocytoma should be considered as a rare cause of dilated cardiomyopathy of uncertain aetiology.


Subject(s)
Adrenal Gland Neoplasms/complications , Cardiomyopathy, Dilated/etiology , Pheochromocytoma/complications , Adrenal Gland Neoplasms/diagnostic imaging , Adrenal Gland Neoplasms/surgery , Cardiomyopathy, Dilated/therapy , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/therapy , Electrocardiography/methods , Humans , Hypertension/complications , Hypertension/therapy , Male , Middle Aged , Pheochromocytoma/diagnostic imaging , Pheochromocytoma/surgery , Tomography, X-Ray Computed/methods
2.
Emerg Med J ; 20(3): E4, 2003 May.
Article in English | MEDLINE | ID: mdl-12748167

ABSTRACT

A 41 year old woman with type 2 diabetes, hypertension, and hyperlipidaemia but no known heart disease received 130 DC shocks for repeated cardiac arrests due to ventricular tachyarrhythmias over 48 hours. She was stabilised by intravenous amiodarone and had a defibrillator implanted. Serial ECGs did not change, but raised troponin I confirmed myocardial infarction as the underlying cause. Electrical storm is an uncommon and dramatic but usually treatable syndrome of recurrent ventricular arrhythmias. Frequent precipitants of electrical storm include recent worsening heart failure, hypokalaemia, hypomagnesaemia and myocardial ischaemia. Amiodarone is the antiarrhythmic agent of choice and implantable cardioverter defibrillator improves long term outcome.


Subject(s)
Electric Countershock , Tachycardia, Ventricular/therapy , Ventricular Fibrillation/therapy , Adult , Amiodarone/therapeutic use , Anti-Arrhythmia Agents/therapeutic use , Combined Modality Therapy , Female , Heart Arrest/therapy , Humans , Myocardial Infarction/complications
4.
Br Heart J ; 73(2): 125-8, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7696020

ABSTRACT

OBJECTIVE: To determine whether the interval between the onset of symptoms of acute myocardial infarction and the patient's call for medical assistance (patient delay) is related to left ventricular function at the time of presentation. DESIGN: Prospective observational study. SETTING: Coronary care unit of Aberdeen Royal Infirmary. PATIENTS: 93 consecutive patients with acute myocardial infarction. MAIN OUTCOME MEASURES: Left ventricular stroke distance, expressed as a percentage of the age predicted normal value, measured first on admission, and then daily for 10 days or until discharge. Patients were questioned at admission to determine the time of onset of symptoms and the time of their call for medical assistance. RESULTS: Median (range) patient delay was 30 (1-360) min. Mean (SD) stroke distance on admission was 70(18)%, rising to 77(19)% on the second recording, and to 84(18)% on the day of discharge. Linear regression of log(e)(patient delay) against first, second, and last measurements of stroke distance gave correlation coefficients of 0.28 (P < 0.01), 0.18 (not significant), and 0.11 (not significant), respectively. CONCLUSIONS: Patient delay within the first 4 h after the onset of symptoms of acute myocardial infarction is positively related to left ventricular function on admission. A possible explanation is that deteriorating left ventricular function influences the patient's decision to call for help. This tendency for patients with more severe infarction to call for help sooner is an added reason for giving thrombolytic treatment at the first opportunity: those who call early have most to gain from prompt management.


Subject(s)
Myocardial Infarction/physiopathology , Patient Acceptance of Health Care , Ventricular Function, Left/physiology , Electrocardiography , Humans , Middle Aged , Myocardial Infarction/complications , Myocardial Infarction/drug therapy , Prospective Studies , Regression Analysis , Thrombolytic Therapy , Time Factors
5.
Eur Heart J ; 14 Suppl B: 35-9, 1993 Jul.
Article in English | MEDLINE | ID: mdl-8370371

ABSTRACT

This randomized, double-blind, parallel study compared the anti-anginal effects of nicorandil and atenolol in 37 patients with exercise-induced angina pectoris. At the end of a single-blind placebo period, patients were randomized and received either atenolol 50 mg o.d. or nicorandil 10 mg b.d. for 3 weeks. On the third week, the dosage was increased (nicorandil 20 mg b.d. or atenolol 100 mg o.d.) for the final 3-week period. Treadmill exercise tolerance tests were performed immediately before and 2 h after dosing at the end of the placebo period, and at the end of the third and sixth week of active treatment. Demographic characteristics and exercise performance with placebo were comparable between both treatment groups, and at the end of the treatment periods a significant improvement in exercise time was observed: an increase in the time to peak exercise of 1.33 +/- 0.29 min (mean +/- standard error of the mean) in atenolol-treated patients (P < 0.001), and of 1.47 +/- 0.40 min (P < 0.005) in nicorandil-treated patients. While the anti-anginal activity of the two drugs was comparable, their effects on the rate-pressure product heart rate x systolic blood pressure were clearly different; atenolol induced a decrease at peak exercise, but this parameter was not changed or was slightly increased with nicorandil. One patient with severe three-vessel disease died suddenly after 3 days of treatment with nicorandil 10 mg twice daily. The most frequent adverse effect in both groups was headache, which led to discontinuation of one patient in the atenolol group and of five patients in the nicorandil group.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Angina Pectoris/drug therapy , Atenolol/therapeutic use , Electrocardiography/drug effects , Exercise Test/drug effects , Niacinamide/analogs & derivatives , Vasodilator Agents/therapeutic use , Aged , Angina Pectoris/physiopathology , Atenolol/adverse effects , Blood Pressure/drug effects , Blood Pressure/physiology , Coronary Circulation/drug effects , Coronary Circulation/physiology , Coronary Disease/drug therapy , Coronary Disease/physiopathology , Double-Blind Method , Female , Heart Rate/drug effects , Heart Rate/physiology , Humans , Male , Middle Aged , Niacinamide/adverse effects , Niacinamide/therapeutic use , Nicorandil , Vasodilator Agents/adverse effects
6.
Am J Cardiol ; 71(1): 40-4, 1993 Jan 01.
Article in English | MEDLINE | ID: mdl-8420234

ABSTRACT

Two hundred thirty-six patients with peripheral vascular disease were prospectively studied to assess whether noninvasive cardiac investigations could predict prognosis better than simple clinical assessment. Clinical history, examination and resting electrocardiography were considered in all patients; exercise electrocardiography, Holter monitoring, radionuclide ventriculography and dipyridamole thallium imaging were performed in a subgroup of 168 patients. Follow-up for 6 to 30 months revealed major cardiac events in 21 patients. Cox survival analysis showed that clinical evidence of prior coronary artery disease was the best variable from clinical assessment that predicted cardiac events, with no other clinical variable adding to the statistical model. When variables from noninvasive cardiac assessment were added to the model, which included clinical evidence of coronary artery disease, dipyridamole thallium heart:lung ratio and left ventricular ejection fraction added significantly and incrementally to the prediction of cardiac events. Results of exercise electrocardiography or Holter monitoring did not add significantly. It is concluded that high lung uptake of thallium during dipyridamole stress, and impaired left ventricular ejection fraction help to identify patients with peripheral vascular disease who are at high cardiac risk, and should therefore be used for selecting subsequent cardiovascular medical, surgical and anesthetic management.


Subject(s)
Coronary Disease/diagnosis , Heart Function Tests , Intermittent Claudication/complications , Aged , Cardiac Catheterization , Dipyridamole , Electrocardiography , Electrocardiography, Ambulatory , Exercise Test , Female , Follow-Up Studies , Humans , Male , Prognosis , Prospective Studies , Radionuclide Ventriculography , Stroke Volume , Survival Analysis , Technetium , Thallium Radioisotopes
7.
J Laryngol Otol ; 106(11): 996-7, 1992 Nov.
Article in English | MEDLINE | ID: mdl-1479281

ABSTRACT

Dyskeratosis congenita is a multisystem disorder with an increased incidence of neoplasia and opportunistic infections. A case is reported as a cause of complete nasopharyngeal atresia.


Subject(s)
Adenocarcinoma/complications , Hyperpigmentation/complications , Leukoplakia/complications , Lung Neoplasms/complications , Nails, Malformed , Nasopharynx/abnormalities , Aged , Humans , Male , Syndrome
9.
Am J Cardiol ; 66(7): 679-82, 1990 Sep 15.
Article in English | MEDLINE | ID: mdl-2144705

ABSTRACT

The efficacy of nicorandil was compared with atenolol in 37 patients with chronic stable angina using a randomized, placebo-controlled, parallel study design. After a single-blind placebo phase, patients were randomized to receive nicorandil or atenolol using a double-dummy technique. Patients took nicorandil 10 mg twice daily or atenolol 50 mg once daily for the first 3 weeks, and if no adverse effects were encountered they took nicorandil 20 mg twice daily or atenolol 100 mg once daily, for the final 3-week phase. Treadmill exercise tests were performed at the end of each treatment phase immediately before and 2 hours after the morning dose of medication. Groups were demographically similar. Placebo exercise times were 7.06 (0.60) minutes (mean +/- standard error of the mean) in the nicorandil group and 6.81 (0.47) minutes in the atenolol group. After 6 weeks, improvements in exercise time were before dosing: +1.47 (0.40) minutes with nicorandil (p less than 0.005) and +1.33 (0.29) minutes with atenolol (p less than 0.001). Improvements after therapy was administered were +2.45 (0.41) minutes with nicorandil (p less than 0.001) and +2.37 (0.43) minutes with atenolol (p less than 0.0001). Whereas, the predose peak exercise double product (heart rate X systolic blood pressure mm Hg/100) was reduced with atenolol (-43.6 units; p less than 0.001), an increase (+7.56 units; difference not significant) was noted with nicorandil. One patient taking atenolol and 5 taking nicorandil developed persistent headaches. One subject with severe 3-vessel coronary artery disease had fatal myocardial infarction within 3 days of starting nicorandil, 10 mg twice daily.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Angina Pectoris/drug therapy , Atenolol/therapeutic use , Niacinamide/analogs & derivatives , Vasodilator Agents/therapeutic use , Drug Administration Schedule , Electrocardiography , Exercise Test , Female , Headache/chemically induced , Humans , Male , Middle Aged , Niacinamide/adverse effects , Niacinamide/therapeutic use , Nicorandil , Randomized Controlled Trials as Topic , Single-Blind Method , Vasodilator Agents/adverse effects
12.
Fla Dent J ; 53(3): 24-5, 1982.
Article in English | MEDLINE | ID: mdl-6963570

Subject(s)
Beverages , Animals , Coffee , Milk , Tea , Water
13.
Fla Dent J ; 52(2): 32-3, 1981.
Article in English | MEDLINE | ID: mdl-6949770
SELECTION OF CITATIONS
SEARCH DETAIL
...